Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02689063 · ClinicalTrials.gov registry record · Phase 3
Maxigesic IV Phase 3 Bunionectomy Study
A Phase 3 study of Postoperative Pain, sponsored by AFT Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 276
- Enrollment target
- 2
- Study locations
NCT02689063: Completed Phase 3 study of Postoperative Pain, sponsored by AFT Pharmaceuticals.
NCT02689063 is a Phase 3 study of Postoperative Pain that has completed, run by AFT Pharmaceuticals. The registered enrollment target is 276 participants, above the 230-participant average among 120 other Postoperative Pain trials with a reported enrollment target (20% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02689063, a Phase 3 study of Postoperative Pain, has completed, sponsored by AFT Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 276 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of the study is to determine the clinical efficacy and safety of Maxigesic IV, acetaminophen IV, Ibuprofen IV versus placebo IV for the treatment of acute postoperative pain after bunionectomy
Primary Outcome
A Pain Intensity Difference (PID) is the difference between the Visual Analogue Scale (VAS) pain intensity score recorded at baseline and a score recorded at any time after the first dose of study medication. Taken together, a patient's PID scores capture the pain relief profile attributable to the assigned study medication. A high PID score indicates a better pain relief experienced. The extent of pain relief can then be calculated by the Area Under the Curve the PID scores (also referred to a
Conditions Studied
Interventions
- DRUG Placebo IV
- DRUG IV Acetaminophen
- DRUG IV Ibuprofen
- DRUG Maxigesic IV
Study Locations (2)
Maryland
- Chesapeake Reserach Group - Pasadena
Texas
- Optimal Research - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 276 participants |
| Start Date | 2016-10-26 |
| Est. Completion | 2017-09-15 |
| Phase | Phase 3 |
What the finished NCT02689063 record still lists
NCT02689063 is an interventional study that assigns participants to a tested intervention. The registered 276 participants enrollment target is mid-sized for trials with a published cap, above the 230-participant average among 120 other Postoperative Pain trials with a reported enrollment target (20% higher).
The record links to 1 condition, with Postoperative Pain appearing as the primary indexed condition, and to 4 interventions - of which Placebo IV is the first listed.
NCT02689063 reports a single indexed study location in Maryland, Texas.
Frequently Asked Questions
What is clinical trial NCT02689063 about?
NCT02689063 is a clinical study titled "Maxigesic IV Phase 3 Bunionectomy Study". The purpose of the study is to determine the clinical efficacy and safety of Maxigesic IV, acetaminophen IV, Ibuprofen IV versus placebo IV for the treatment of acute postoperative pain after bunionectomy
What is the current status of trial NCT02689063?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 276 participants. The study started on 2016-10-26. Estimated completion is 2017-09-15.
What conditions does trial NCT02689063 study?
This clinical trial studies the following conditions: Postoperative Pain.
What interventions are being tested in trial NCT02689063?
The interventions under investigation include: Placebo IV (DRUG), IV Acetaminophen (DRUG), IV Ibuprofen (DRUG), Maxigesic IV (DRUG).
Who is sponsoring clinical trial NCT02689063?
This trial is sponsored by AFT Pharmaceuticals, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02689063 being conducted?
This trial has 2 study locations across Maryland, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02689063's enrollment target sits among peer trials
276 23rd of 120 higher than 98 of 120 other Postoperative Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postoperative Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of TLC590 for Postsurgical Pain Following Bunionectomy
RECRUITING · Phase 3
-
A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain
RECRUITING · Phase 3
-
RADA16 for Adult Tonsillectomy
RECRUITING · Phase 3
-
Methadone in TKA for Post-op Pain and Opioid Reduction
RECRUITING · Phase 3
-
Methadone in THA for Post-op Pain and Opioid Reduction
RECRUITING · Phase 3
-
Perioperative Lidocaine and Ketamine in Abdominal Surgery
ACTIVE NOT RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01371630 · 276 participants · Phase 1
Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia
- NCT04192344 · 276 participants · Phase 1
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor
- NCT05294991 · 276 participants · NA
Wellness App for Sleep Disturbance in Hematological Cancer Patients
- NCT05610852 · 276 participants · NA
Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI